You are here: Home / Resources / News and Events / Seminar Series / Fentanyl Analogs and their Role in the Opioid Crisis - Dr. Barry Logan

Fentanyl Analogs and their Role in the Opioid Crisis - Dr. Barry Logan

Main Content

VP Forensic Science Initiatives and Chief of Forensic Toxicology, NMS Laboratories

Event Date:

13 November 2017 from 12:20 PM to 1:10 PM


113 Carnegie Building

Add event to calendar:

vCal  iCal

Biographical Information:Dr. Barry Logan Photo

Dr. Barry K. Logan is Sr. Vice President of Forensic Science Initiatives, Chief Scientist, at NMS Labs in Willow Grove, Pennsylvania, where his responsibilities include management of toxicology resources, new test design and development, and expert testimony in forensic toxicology and chemistry.

Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over one hundred (100) publications and four hundred (400) presentations in forensic toxicology and analytical chemistry, including work on the effects of methamphetamine, cocaine and marijuana on drivers, drug caused and related death.

His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs.

Dr. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and Executive Director at the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in suburban hiladelphia. He holds academic appointments at Indiana University, Arcadia University and Thomas Jefferson University.

In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and in 2013-14 served as President of the American Academy of Forensic Sciences (AAFS).

Click here for formal announcement.

Filed under: